Golden Meditech Holdings Limited provided unaudited earnings guidance for the year ended March 31, 2019. The Group expects to record a substantial increase in loss from operations for the year ended 31 March 2019 by more than 80% as compared to that reported for the year ended 31 March 2018. Such increase in loss from operations for the year ended 31 March 2019 was mainly attributable to an impairment loss on other receivables of approximately HKD 379 million resulting from the further downgrading of Sanpower's credit rating.